What is the differential diagnosis for a patient with leukocytosis, absolute lymphocytosis, monocytosis, eosinophilia, and normal flow cytometry (FACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Differential Diagnosis: Leukocytosis with Lymphocytosis, Monocytosis, Eosinophilia, and Normal Flow Cytometry

With normal flow cytometry excluding clonal lymphoproliferative disorders, this constellation of findings most strongly suggests either a reactive process (infection, inflammatory condition, drug reaction) or an advanced myeloid neoplasm, particularly systemic mastocytosis with associated hematologic neoplasm (SM-AHN) or chronic myelomonocytic leukemia (CMML).

Primary Diagnostic Considerations

Reactive/Secondary Causes (Most Common with Normal FACS)

Since flow cytometry is normal, clonal B-cell lymphoproliferative disorders like CLL are effectively excluded 1. The normal FACS result makes reactive etiologies the leading consideration:

  • Infections: Particularly viral (EBV, CMV), parasitic, or fungal infections can produce this pattern
  • Inflammatory/Autoimmune conditions: Inflammatory bowel disease, vasculitis, connective tissue disorders
  • Drug reactions: Particularly antibiotics, anticonvulsants, allopurinol
  • Allergic conditions: Severe atopic disease, drug hypersensitivity

Myeloid Neoplasms Requiring Urgent Evaluation

Despite normal lymphocyte flow cytometry, myeloid malignancies remain critical to exclude 2:

Systemic Mastocytosis with AHN

  • Leukocytosis, monocytosis, and eosinophilia (L/M/E) are characteristic findings in advanced SM, particularly SM-AHN 2
  • Median counts in SM-AHN: leukocytes 10.2 × 10⁹/L, monocytes 0.9 × 10⁹/L, eosinophils 0.3 × 10⁹/L
  • Flow cytometry of lymphocytes would be normal, but mast cell evaluation and KIT D816V mutation testing are required
  • Associated with ASXL1, SRSF2, and TET2 mutations 2

Chronic Myelomonocytic Leukemia (CMML)

  • Monocyte repartitioning by flow cytometry can distinguish CMML from reactive causes 3
  • Requires absolute monocyte count ≥1.0 × 10⁹/L and ≥10% of WBC differential
  • Bone marrow examination with cytogenetics and molecular studies needed

Myeloid/Lymphoid Neoplasms with Eosinophilia

  • Consider PDGFRA, PDGFRB, or FGFR1 rearrangements 4
  • These present with eosinophilia and can have concurrent lymphocytosis/monocytosis
  • Requires FISH or molecular testing for tyrosine kinase fusion genes

Critical Peripheral Blood Smear Findings

Examine the smear for 5:

  • Dysplasia: Hypogranular or hypolobated neutrophils, pseudo-Pelger-Huët cells (suggests myeloid neoplasm)
  • Blast count: Any blasts or blast equivalents mandate bone marrow examination
  • Lymphocyte morphology: Monomorphic vs. pleomorphic population (normal FACS suggests pleomorphic/reactive)
  • Eosinophil morphology: Abnormal granulation or vacuolization suggests neoplastic process
  • Activated neutrophils: Toxic granulation, Döhle bodies, vacuolization (suggests infection)

Prognostic Thresholds in Advanced Disease

If myeloid neoplasm confirmed, specific count thresholds predict survival 2:

  • Leukocytosis ≥16.8 × 10⁹/L: median OS 1.6 vs 4.7 years
  • Monocytosis ≥1.1 × 10⁹/L: median OS 2.9 vs 4.8 years
  • Eosinophilia ≥1.5 × 10⁹/L: median OS 1.7 vs 5.0 years

Diagnostic Algorithm

  1. Confirm CBC and differential - repeat if discordant with clinical picture 5

  2. Peripheral blood smear review - look for dysplasia, blasts, activated neutrophils 5

  3. Clinical context assessment:

    • Constitutional symptoms (fever, night sweats, weight loss) → higher suspicion for malignancy
    • Recent infections, medications, allergic symptoms → favor reactive
    • Organomegaly, skin lesions, flushing → consider systemic mastocytosis

  4. If smear shows dysplasia, blasts, or abnormal cells:

    • Bone marrow examination with flow cytometry, cytogenetics, molecular studies 4, 3
    • KIT D816V mutation testing if mastocytosis suspected
    • FISH for PDGFRA/PDGFRB/FGFR1 rearrangements if eosinophilia prominent

  5. If smear appears reactive:

    • Infectious workup (viral serologies, parasitic evaluation)
    • Inflammatory markers (ESR, CRP)
    • Review medications
    • Repeat CBC in 2-4 weeks - persistent unexplained findings warrant hematology referral

Critical Pitfalls

  • Do not assume normal lymphocyte flow cytometry excludes all hematologic malignancies - myeloid neoplasms and mastocytosis require different testing 2
  • Monocytosis with eosinophilia in SM-AHN is associated with poor prognosis and additional mutations (ASXL1, SRSF2, TET2) 2
  • Peripheral blood smear is mandatory - automated differentials miss dysplasia and abnormal morphology 5
  • Any blast count >1% requires immediate bone marrow examination 5

References

5
Research

Malignant or benign leukocytosis.

Hematology. American Society of Hematology. Education Program, 2012

Related Questions

What symptoms should be asked about in a patient with leukocytosis to evaluate infection, thrombosis, medication effects, and inflammatory processes?
In a 32‑year‑old man with a history of marijuana use who presents with right‑leg tingling, leukocytosis (white blood cell count 12.7 ×10⁹/L) with absolute neutrophil count 10,668/µL, albumin 5.2 g/dL, and normal erythrocyte sedimentation rate and C‑reactive protein, what is the appropriate initial diagnostic work‑up and management?
Given a complete blood count showing leukocytosis (14,210/µL) with neutrophilia (6,820/µL), eosinophilia (852/µL), basophilia (142/µL), lymphocytosis (5,542/µL), monocytosis (710/µL) and 142 reactive lymphocytes, what is the likely diagnosis and what initial work‑up and management should be pursued?
What is the initial management according to Brazilian guidelines for a patient with leukocytosis (14,210 cells/µL) showing neutrophilia, eosinophilia (852 cells/µL), basophilia, lymphocytosis, monocytosis, and reactive lymphocytes?
What is the most likely diagnosis and recommended management for a patient with leukocytosis (WBC 14.6 K/µL) due to neutrophilia (absolute neutrophil count 11.5 ×10³/µL) and borderline monocytosis, normal red blood cell indices, and HbA1c 5.6%?
What is the recommended treatment for an uncomplicated urinary tract infection in an adult patient who is allergic to penicillins, trimethoprim‑sulfamethoxazole, and amoxicillin‑clavulanate?
Explain the surgical anatomy of inguinal hernias.
Which tendon is affected in an ischial avulsion injury after a fall?
If ziprasidone (Geodon) at 40 mg is causing akathisia, can I discontinue it and switch to olanzapine?
What is the appropriate management for left lower quadrant abdominal pain associated with constipation, without swelling or tenderness?
Should a patient with confirmed celiac disease and an underweight body‑mass index be referred to a registered dietitian for gluten‑free nutrition counseling?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.